doi: 10.1016/j.xcrm.2021.100387 104 ArodaVRAberleJBardtrumLChristiansenEKnopFKGaberySet al
4 Results based on a January 2026 analysis of 14,203 Noom GLP-1 Rx Program members who actively logged weight over a 40-week period
The new Medicare program covering GLP-1 weight-loss medications, Wegovy and Zepbound, has sparked significant interest and confusion among seniors
Ozempic for weight loss: Does it work, and what do experts recommend
GLP-1 receptor activation The GLP-1 component of retatrutide reduces appetite through multiple mechanisms: slowing gastric emptying (food stays in your stomach longer, so you feel full sooner), signaling satiety centers in the brain (your brain gets a stronger "stop eating" signal), and enhancing insulin secretion in response to meals
Her work has appeared in publications like Mens Health , Womens Health , AARP The Magazine , EatingWell and Prevention , and she has also led strategic communications for a top engineering college and a global oncology company.